News

IEEE2d
Identification of Neurodegenerative Diseases From Gait Rhythm Through Time Domain and Time-Dependent Spectral Descriptors
Abstract: The analysis of gait rhythm by pattern recognition can support the state-of-the-art clinical methods for the identification of neurodegenerative diseases (NDD). In this study, we ...
ascopubs.org2d
Initial safety run-in results of the phase III POLARGO trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients (pts) with relapsed/refractory ...
Impact of bone marrow involvement in patients with peripheral T-cell lymphoma undergoing autologous stem cell transplant. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
ascopubs.org4d
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
MRD positivity or reappearance was prognostic for earlier clinical relapse. This study leverages a large phase III trial to demonstrate the association of MRD status with outcomes in patients with FL.
gut.bmj4d
Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials
Mayo Clinic College of Medicine, Department of Internal Medicine, Jacksonville, Florida, USA Background: Functional dyspepsia (FD) is a common disorder but there is currently little efficacious drug ...